Evofem Biosciences, Inc.
EVFM
|
$0.0136
600K
|
Health Technology
(0.0% 1d) (-20.5% 1m) (-20.5% 1y) (0.0% 2d) (0.0% 3d) (2.0% 7d) (99.45% volume)
Earnings Calendar: 2023-01-12
Market Cap: $ 733,861
http://www.evofem.com
Sec Filling | Patents | 53 employees
(US) Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
hormone women injection
add to watch list Paper trade email alert is off
Press-releases
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
Published: 2024-03-27 (Crawled : 12:30) - prnewswire.com
EVFM | $0.0136 600K
|
Health Technology
|
| O: 4.4%
H: 52.63%
C: 36.84%
ADTX | $2.35 14K
|
Health Technology
|
| O: 2.74%
H: 0.0%
C: -4.7%
sales phexxi million
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
ADTX | $2.35 14K
|
Health Technology
|
| O: -1.3%
H: 2.11%
C: -1.58%
sales phexxi
Colposcopy Devices Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5% by 2028, Predicts DelveInsight
Published: 2024-01-26 (Crawled : 22:00) - prnewswire.com
EVFM | $0.0136 600K
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.49 1.36% 720K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $748.11 -0.35% 190K
|
Health Technology
| Email alert
Add to watchlist
PHG | News | $20.05 -0.5% 58K
|
Health Technology
| Email alert
Add to watchlist
PKX | $70.575 3.94% 19K
|
Non-Energy Minerals
| Email alert
Add to watchlist
global growth market
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
ADTX | $2.35 14K
|
Health Technology
|
| O: 7.27%
H: 1.47%
C: -5.49%
disease life million cancer sciences platform
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc.
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
ADTX | $2.35 14K
|
Health Technology
|
| O: 84.99%
H: 35.14%
C: -13.37%
acquire agreement
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
Published: 2023-11-14 (Crawled : 15:30) - biospace.com/
EVFM | $0.0136 600K
|
Health Technology
| Email alert
Add to watchlist
financial results
Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023
Published: 2023-10-24 (Crawled : 13:00) - biospace.com/
EVFM | $0.0136 600K
|
Health Technology
| Email alert
Add to watchlist
results
Evofem to Participate in the Virtual Investor Ask the CEO Conference
Published: 2023-10-13 (Crawled : 15:30) - prnewswire.com
EVFM | $0.0136 600K
|
Health Technology
| Email alert
Add to watchlist
ceo conference
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
Published: 2023-09-27 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.0354 34K
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
phexxi fda approval market
Fertility Supplement Global Market to Exhibit Growth at a CAGR of ~8% by 2028 | DelveInsight
Published: 2023-08-28 (Crawled : 22:00) - prnewswire.com
EVFM | $0.0136 600K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
global growth market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 75% | 25% |
Top 10 Gainers
TIRX | $1.13 133.09% 44M
|
AGBA | $0.8978 124.45% 60M
|
Finance
BPTH | $6.18 90.74% 39M
|
Health Technology
INVO | $1.44 89.47% 3M
|
Health Technology
SINT | $0.0588 57.64% 240M
|
Health Technology
XPON | $2.66 37.82% 5.2M
|
THCH | $1.38 32.69% 9.9M
|
n/a
ALRN | $5.605 31.88% 210K
|
Health Technology
HOLO | $2.92 30.36% 22M
|
VTNR S | $1.25 27.66% 3.2M
|
Industrial Services
Last 48 Hours Insiders Buying
RELL | $10.0 1.42% 13K
|
Electronic Technology
|
13:30
IZEA | $2.53 15K
|
Technology Services
|
00:00
RKT P 383 | $11.61 2.02% 96K
|
Finance
|
22:30
CTRN P 18090 | $22.805 1.94% 12K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% 41K
|
Energy Minerals
|
21:00
NEOG P 10000 | $11.96 -1.48% 140K
|
Health Technology
|
16:30
RMCF | $3.53 360
|
Consumer Non-Durables
|
20:10